|
WO9966065A2
|
|
Proteasomal activity
|
|
GB9817693D0
|
|
Virally-mediated targeting of drugs and genetic material
|
|
GB9815083D0
|
|
Cooperative MC6-mediated activation of 20S proteaSOMES
|
|
GB9812757D0
|
|
Assay procedure for identifying inhibitors of the protease-inhibitory function of the human immunodeficiency virus tat protein
|
|
GB9812759D0
|
|
A procedure for generating resistance to bacterial or viral infection damage
|
|
GB9812760D0
|
|
A method for identifying compounds which inhibit viral replication and pathogenesis
|
|
GB9812756D0
|
|
Assay procedure for identifying inhibitors of the nuclease-inhibitory function of the human immunodeficiency virus tat protein
|
|
GB9812758D0
|
|
Proteasomal destruction of mRNA
|
